Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study location entry has been updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333. This reflects a shift to a city-level designation for the site, which may influence where participants travel to enroll.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a release of the site software rather than changing the clinical trial details.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check38 days agoChange DetectedReplaced the Italy location entry from Padua to Padova (postal code 35128). The Padua listing was removed and the Padova listing added.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision information updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check60 days agoChange DetectedNo additions or deletions detected; the page content and structure appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.